PD-1 expression levels have been associated with outcomes in other malignancies [10], such as diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia, and we speculated on potential associations between reduced PD-1 staining and disease progression or worse outcomes in MF. Here, PDCD1 is linked to diffuse large B-cell lymphoma.